Study of STI-1386 virus for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new treatment that uses a specially designed virus to target and attack cancer cells. It is for people with certain advanced solid tumors that have not responded to previous treatments or have come back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (not brain) like advanced pancreatic cancer, soft tissue sarcoma, or liver metastases from colorectal cancer that has returned or not responded to treatment.
- You have at least one measurable tumor that can be seen on scans.
- You are able to care for yourself and are not bedridden (ECOG score 0-2).
- You have recovered from major side effects of previous treatments.
- You have not had high-dose steroids within 2 weeks before the study starts.
- You are willing to follow contraception guidelines and the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests an experimental drug called STP938 (Dencatistat) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and how well it works against different cancer types.
This trial tests a new drug called AK138D1 for people with advanced solid tumors that have not responded to or can't tolerate standard treatments. The goal is to see if it is safe and effective.
This early-phase study tests STI-7349 (a new cancer treatment) in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see how well it can control cancer.
This trial tests a new drug called AK138D1 for people with advanced solid tumors. It aims to see if the drug is safe and how well it works, especially for tumors that haven't been treated with HER3-targeted therapy before.
This trial tests a new drug called GI-108, which is designed to help your immune system fight cancer. It is for people with advanced or metastatic solid tumors that have not responded to other treatments.
This trial tests a new drug, ST-01156, designed to attack cancer cells by breaking down a protein called RBM39. It may be an option for people with advanced solid tumors that have not responded to other treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.